Departed
Daniel Burgess
Director
ABUS ·
Arbutus Biopharma Corp
Daniel Burgess
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4101–4150 of 34667
Departed
James Meyers
Director
ABUS ·
Arbutus Biopharma Corp
James Meyers
Departed
Richard C. Henriques
Director
ABUS ·
Arbutus Biopharma Corp
Richard C. Henriques
Departed
Frank Torti
Director
ABUS ·
Arbutus Biopharma Corp
Frank Torti, M.D., chairperson of the Board
Departed
Melissa V. Rewolinski
Director
ABUS ·
Arbutus Biopharma Corp
Melissa V. Rewolinski, Ph.D.
Departed
Keith Manchester
Director
ABUS ·
Arbutus Biopharma Corp
Keith Manchester, M.D.
Departed
Michael J. McElhaugh
Director
ABUS ·
Arbutus Biopharma Corp
Michael J. McElhaugh
Appointed
Mark Kaye
Director
CNMD ·
CONMED Corp
On February 24, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Mark Kaye as a director effective immediately.
Appointed
Tien Tzuo
Class I director
AMPL ·
Amplitude, Inc.
On February 22, 2025, the Board of Directors (the “Board”) of Amplitude, Inc. (the “Company”) appointed Tien Tzuo to serve as a Class I director
Departed
John R. Miller III
Director
MIDD ·
MIDDLEBY Corp
John R. Miller III notified the Board of his intent to retire from the Board, effective upon the completion of the 2025 Annual Meeting.
Appointed
Ed Garden
Director
MIDD ·
MIDDLEBY Corp
appointed Julie Bowerman and Mr. Garden as directors of the Company to fill the vacancies so created.
Appointed
Julie Bowerman
Director
MIDD ·
MIDDLEBY Corp
appointed Julie Bowerman and Mr. Garden as directors of the Company to fill the vacancies so created.
Departed
Gerard Cunningham
Director
STEM ·
STEM, INC.
On February 25, 2025, Gerard Cunningham notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective February 28, 2025 for personal reasons.
Appointed
Jerome Durso
Director
ALT ·
Altimmune, Inc.
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.
Appointed
Teri Lawver
Director
ALT ·
Altimmune, Inc.
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.
Departed
John C. Malone
Director
QVCGA ·
QVC Group, Inc.
As previously announced by the Company on its Current Report on Form 8-K filed on September 25, 2024, John C. Malone, a member of the Board, will not stand for reelection and will cease being a member of the Board when his current term expires at the 2025 annual meeting.
Departed
Andrea L. Wong
Director
QVCGA ·
QVC Group, Inc.
On February 19, 2025, Andrea L. Wong notified QVC Group, Inc. (the “ Company ”) that she does not intend to stand for reelection as a member of the Board of Directors (the “ Board ”) of the Company.
Departed
William McDevitt
Director
BMRC ·
Bank of Marin Bancorp
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Departed
Sanjiv Sanghvi
Director
BMRC ·
Bank of Marin Bancorp
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Departed
Wayne Edmunds
Director
MSCI ·
MSCI Inc.
Mr. Wayne Edmunds informed MSCI Inc. (“MSCI” or the “Company”) of his decision to retire from the Board of Directors (the “Board”) of the Company and not stand for re-election at the Company’s 2025 Annual Meeting of Shareholders.
Departed
Marino Papazoglou
director
JFIL ·
Jubilant Flame International, Ltd
On February 25, 2025, the company’s Board of Directors resolved to acknowledge that Mr. Marino Papazoglou has resigned from the board as a director of the company, effective immediately.
Departed
Nima Besharat
Director
PAPL ·
Pineapple Financial Inc.
On February 18, 2025, the Board of Pineapple Financial Inc. (the " Company ") received by email a resignation letter from Nima Besharat, a director of the Company, pursuant to which Mr. Besharat resigned as director of the Company, effective immediately.
Departed
Rachel King
Director
CBIO ·
CRESCENT BIOPHARMA, INC.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
Departed
Harout Semerjian
Director
CBIO ·
CRESCENT BIOPHARMA, INC.
Mr. Semerjian also resigned from the Board of Directors effective as of February 21, 2025.
Departed
Mark Goldberg
Director
CBIO ·
CRESCENT BIOPHARMA, INC.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
Departed
Scott Jackson
Director
CBIO ·
CRESCENT BIOPHARMA, INC.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
Departed
Scott Koenig
Director
CBIO ·
CRESCENT BIOPHARMA, INC.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
Departed
Amy Butte
Director
DOCN ·
DigitalOcean Holdings, Inc.
On February 21, 2025, Amy Butte, a member of the Board of Directors (the “Board”) of the Company, notified the Company of her intention not to stand for reelection at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
Appointed
Deborah Ellinger
Class II Director
CHWY ·
Chewy, Inc.
On February 21, 2025, the board of directors (the “Board”) of Chewy, Inc. (the “Company”) increased the size of the Board from twelve to thirteen directors and filled the newly created vacancy by appointing Ms. Deborah Ellinger (the “New Director”) as a Class II director
Departed
Patrick McCarter
Director
GTM ·
ZoomInfo Technologies Inc.
the resignation of Patrick McCarter, which was received February 19, 2025 and will become effective at the end of the day on February 28, 2025.
Appointed
Rob Giglio
Director
GTM ·
ZoomInfo Technologies Inc.
the Company announced the appointment of Rob Giglio to its Board of Directors (“Board”), effective as of March 1, 2025.
Appointed
Daniel Rivera
director
DRVN ·
Driven Brands Holdings Inc.
the Board approved increasing the size of the Board to 11 members and electing Mr. Rivera to serve as a director, both effective as of the Transition Date.
Departed
C. Todd Asbury
director
NWPP ·
NEW PEOPLES BANKSHARES INC
director C. Todd Asbury will not stand for reelection and will step down from the board of directors effective with the Annual Meeting of Shareholders scheduled for May 20, 2025.
Appointed
Tomasz Anczok
Independent Director
MGNC ·
Mag Magna Corp
On February 21, 2025, Mag Magna Corp (the "Registrant") approved the appointment of Tomasz Anczok, as Independent Director of the Registrant, to be effective as of February 21, 2025
Appointed
Dawn Perry
Director
INDB ·
INDEPENDENT BANK CORP
On February 20, 2025, the Board of Directors (the “Board”) of Independent Bank Corp. (the “Company”) appointed Leif O’Leary, Dawn Perry, and Aparna Ramesh (collectively, the “New Directors”) as members of the Board of Directors of the Company (the “Board”), effective April 1, 2025.
Appointed
Leif O’Leary
Director
INDB ·
INDEPENDENT BANK CORP
On February 20, 2025, the Board of Directors (the “Board”) of Independent Bank Corp. (the “Company”) appointed Leif O’Leary, Dawn Perry, and Aparna Ramesh (collectively, the “New Directors”) as members of the Board of Directors of the Company (the “Board”), effective April 1, 2025.
Appointed
Aparna Ramesh
Director
INDB ·
INDEPENDENT BANK CORP
On February 20, 2025, the Board of Directors (the “Board”) of Independent Bank Corp. (the “Company”) appointed Leif O’Leary, Dawn Perry, and Aparna Ramesh (collectively, the “New Directors”) as members of the Board of Directors of the Company (the “Board”), effective April 1, 2025.
Departed
Mary C. Hemmingsen
Director
ITRI ·
ITRON, INC.
On February 19, 2025, Mary C. Hemmingsen, a member of the Board and a member of the Audit/Finance Committee, advised the Company that owing to her significant work and board load as partner at Moneta Securities and her audit chair role for four companies, she will not stand for re-election to the Board at the Company's 2025 Annual Meeting of Shareholders.
Departed
Lynda L. Ziegler
Director
ITRI ·
ITRON, INC.
On February 19, 2025, Lynda L. Ziegler, a member of the Board of Directors (the Board) of Itron, Inc. (the Company), the chair of the Nominating and Corporate Governance Committee, and a member of the Compensation Committee, notified the Company that she will retire when her term ends and, therefore, not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders.
Departed
Robert A. Rango
member of the Board of Directors
MCHP ·
MICROCHIP TECHNOLOGY INC
On February 19, 2025, Robert A. Rango, a member of the Board of Directors (the "Board") of Microchip Technology Incorporated (the "Company"), retired from the Board effective as of February 19, 2025.
Departed
Dan O. Dinges
Director
CTRA ·
Coterra Energy Inc.
On February 19, 2025, Dan O. Dinges informed the Board of Directors (the “Board”) of Coterra Energy Inc. (the “Company”) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
Departed
Robert S. Boswell
Director
CTRA ·
Coterra Energy Inc.
Also on February 19, 2025, Robert S. Boswell informed the Board of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at the 2025 Annual Meeting.
Appointed
Samraat S. Raha
Director
MYGN ·
MYRIAD GENETICS INC
the Board also appointed Mr. Raha to the Board to serve as a Class II director with a term expiring at the Company’s 2025 Annual Meeting of Stockholders as of the Effective Date to fill the vacancy on the Board that will be created by Mr. Diaz’ resignation.
Appointed
Barak Eilam
Director
PAYO ·
Payoneer Global Inc.
On February 19, 2025, the Board of Directors of the Company (the “Board”), approved an increase in the size of the Board from nine to ten members and appointed Barak Eilam as a director to fill the vacancy created by the increase.
Appointed
Greg Pyszcymuka
Class I director
Evoke Pharma Inc
On February 20, 2025, pursuant to the amended and restated bylaws of Evoke Pharma, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Greg Pyszcymuka to serve as a Class I director, effective immediately, with an initial term expiring at the Company’s 2026 annual meeting of stockholders.
Appointed
Thomas Mullins
independent member of the Board
ASLE ·
AerSale Corp
increased the size of the Board from seven to eight directors and appointed Thomas Mullins to serve as an independent member of the Board to fill the resulting vacancy, effective February 18, 2025
Appointed
Lloyd W. "Billy" Helms, Jr.
Director
CIVITAS RESOURCES, INC.
the board of directors of the Company (the “Board”) increased the size of the Board from nine directors to ten directors and appointed Lloyd W. “Billy” Helms, Jr. to the resulting vacancy, effective immediately.
Departed
Laurance Narbut
Director
BRN ·
BARNWELL INDUSTRIES INC
On February 19, 2025, Mr. Laurance Narbut notified the Board of Directors (the “Board”) of Barnwell Industries, Inc. (the “Company”) that he resigned as a director of the Company, effective February 19, 2025.
Departed
Derek DiRocco, M.D.
Director
HOWL ·
Werewolf Therapeutics, Inc.
On February 19, 2025, Derek DiRocco, M.D., notified Werewolf Therapeutics, Inc. (the “Company”) of his intent to resign from the Board of Directors (the “Board”) of the Company, effective upon the Company’s 2025 annual meeting of stockholders.
Appointed
Anil Singhal, Ph.D.
Director
HOWL ·
Werewolf Therapeutics, Inc.
On February 19, 2025, the Board of the Company, upon recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Anil Singhal, Ph.D., as a director.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.